Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06181344

Implementation and Evaluation of a Fear of Cancer Recurrence Screening, Referral and Management Program for Chinese Cancer Survivors: a Stepped Wedge and Cluster Randomized Trial

Led by The University of Hong Kong · Updated on 2025-01-13

1980

Participants Needed

2

Research Sites

34 weeks

Total Duration

On this page

Sponsors

T

The University of Hong Kong

Lead Sponsor

H

Health and Medical Research Fund

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating a program designed to implement fear of cancer recurrence screening, referral, and management into routine cancer care clinics. This study uses a stepped-wedge cluster randomized controlled trial to compare this implementation program against usual care without such strategies. The study aims to increase both the number of eligible patients screened for fear of cancer recurrence and the number of patients referred for psychosocial support, while also exploring patient and provider experiences to identify factors affecting program adoption and sustainability. The program being tested involves five implementation strategies including training nursing staff, providing weekly audit and feedback reports, facilitating site visits to address operational challenges, and allowing adaptable workflows tailored to each clinic's context. In the control condition, clinics continue their usual operations with the fear of cancer recurrence screening tool and referral forms provided but without the active implementation supports. Patients referred for psychosocial support are managed according to a predefined clinical pathway. Participants will be patients diagnosed with non-metastatic breast, gynecological, or colorectal cancer who completed primary and adjuvant treatment within the past two years. Researchers will track changes in the number of patients screened and referred before and after the implementation over up to 24 months. They will also evaluate referral uptake, staff training numbers, and staff knowledge and confidence about the screening program through surveys and qualitative interviews. The study is sponsored by The University of Hong Kong and aims to complete by August 2026.

CONDITIONS

Brief Title

Implementation and Evaluation of a Fear of Cancer Recurrence Screening, Referral and Management Program

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with non-metastatic breast, gynecological, or colorectal cancer
  • Completed primary and adjuvant treatment within the past two years
  • Adults aged 18 years or older
Not Eligible

You will not qualify if you...

  • Patients beyond two years post-treatment
  • Patients diagnosed with metastatic cancer
  • Patients with non-breast, non-gynecological, and non-colorectal cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Up to 24 months

Participants attend routine oncological clinic visits where a fear of cancer recurrence screening program is implemented using training, audit and feedback, facilitation, and adaptable workflow strategies.

Visits occur as part of routine oncological care over the implementation period

Process Evaluation

Duration - Up to 24 months

Participants and service providers may be invited to participate in qualitative interviews to share their experiences of the implementation program and identify factors influencing its adoption and sustainability.

Interviews conducted at various times during the study

Trial Site Locations

Total: 2 locations

1

KWH Breast clinic

Hong Kong, Hong Kong

Actively Recruiting

2

QMH department of Surgery

Hong Kong, Hong Kong

Actively Recruiting

Loading map...

Research Team

D

Danielle Ng, Phd

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here